Sandbox:Roukoz: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
! colspan="2" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ! colspan="2" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ||
| colspan="5" |'''Physical exam''' | | colspan="5" |'''Physical exam''' | ||
! colspan=" | ! colspan="2" rowspan="2" |Para-clinical findings | ||
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ||
|- | |- | ||
! colspan="5" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Skin Examination | ! colspan="5" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Skin Examination | ||
|- | |- | ||
! colspan=" | ! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diagnosis | ||
|- | |- | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Type | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Type | ||
Line 17: | Line 17: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dermoscopic Findings | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dermoscopic Findings | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology | ||
|- | |- | ||
| rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Cutaneous squamous cell carcinoma''' | | rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Cutaneous squamous cell carcinoma''' | ||
Line 41: | Line 40: | ||
* Pleomorphic keratinocytes | * Pleomorphic keratinocytes | ||
* Hyperchromatic nuclei | * Hyperchromatic nuclei | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Grows slowly, enlarging over the course of years | * Grows slowly, enlarging over the course of years | ||
Line 65: | Line 60: | ||
* In black individuals: legs, anus, areas of chronic inflammation | * In black individuals: legs, anus, areas of chronic inflammation | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Keratinocytic dysplasia involving the full thickness of the epidermis | * Keratinocytic dysplasia involving the full thickness of the epidermis | ||
Line 75: | Line 66: | ||
* Pleomorphic keratinocytes | * Pleomorphic keratinocytes | ||
* Hyperchromatic nuclei | * Hyperchromatic nuclei | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* May be painful or pruritic | * May be painful or pruritic | ||
Line 104: | Line 94: | ||
* Inflammatory infiltrate in the dermis | * Inflammatory infiltrate in the dermis | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Rapid growth (within weeks) | * Rapid growth (within weeks) | ||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Merkel cell carcinoma''' | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Merkel cell carcinoma''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* | * Intracutaneous nodule | ||
| style="background: #F5F5F5; padding: 5px;" | | |||
* Shiny | |||
* Flesh-colored or bluish-red | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
* Firm | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
* Rapidly growing | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Starts on areas | * Starts on Sun-exposed areas | ||
* | * Head and neck | ||
* Upper limbs and shoulder | |||
* Lower limbs and hip | |||
* Trunk | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* | * Milky red areas | ||
* | * Linear | ||
* Irregular vessels | |||
* Polymorphous vessels | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | * Strands of uniform, round, blue cells, with large basophilic nuclei | ||
* Single-cell necrosis | |||
* Frequent mitoses | |||
* Lymphovascular invasion | |||
* Perineural invasion | |||
* Epidermal involvement via pagetoid spread | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
* Usually in older patients with light skin tones | |||
|- | |- | ||
| rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Basal cell carcinoma''' | | rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Basal cell carcinoma''' | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Nodular basal cell carcinoma''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Nodular basal cell carcinoma''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | * Papule | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Flesh-colored | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Variable | * Variable | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Face | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* May have a "rolled" border | |||
* May have a "rolled" border | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Superficial basal cell carcinoma ''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Superficial basal cell carcinoma ''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Patch | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
* Erythematous | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
* Scaly | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Variable | * Variable | ||
Line 151: | Line 159: | ||
* large, hyperchromatic, oval nuclei and little cytoplasm | * large, hyperchromatic, oval nuclei and little cytoplasm | ||
* well differentiated and cells appear histologically similar to basal cells of the epidermis | * well differentiated and cells appear histologically similar to basal cells of the epidermis | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Prurigo nodules''' | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Prurigo nodules''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | * Dome-shaped nodules | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | * Flesh-colored | ||
* Erythematous | |||
* Brown/black | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
* Firm | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
* Few millimeters to several centimeters | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Extensor surfaces of the arms and legs and on the trunk | * Extensor surfaces of the arms and legs and on the trunk | ||
Line 166: | Line 179: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Thick, compact orthohyperkeratosis | * Thick, compact orthohyperkeratosis | ||
* Irregular epidermal | * Irregular epidermal hyperplasia | ||
* Focal parakeratosis with irregular acanthosis | * Focal parakeratosis with irregular acanthosis | ||
* A nonspecific dermal infiltrate containing WBCs | |||
* A nonspecific dermal infiltrate containing | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Nodules range in number from few to hundreds | * Nodules range in number from few to hundreds | ||
* Worsened by heat, sweating, or irritation from clothing | * Worsened by heat, sweating, or irritation from clothing | ||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Common nevus''' | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Common nevus''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Dome-shaped | * Dome-shaped nodules | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* | * Hypopigmented | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Smooth surface | |||
* Terminal hairs often present | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Variable | * Variable | ||
Line 188: | Line 199: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Comma-shaped or curved vessels | * Comma-shaped or curved vessels | ||
* Structureless | * Structureless light brown background | ||
* Residual | * Residual brown thick circles around the hair follicles | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 196: | Line 206: | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Blue nevus''' | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Blue nevus''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* | * Macules | ||
* Papules | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Blue | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 208: | Line 220: | ||
* Structureless blue pigmentation | * Structureless blue pigmentation | ||
* Structureless blue and white or blue and brown on some occasions | * Structureless blue and white or blue and brown on some occasions | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 226: | Line 237: | ||
* Coiled vessels | * Coiled vessels | ||
* White network over a pink to reddish background | * White network over a pink to reddish background | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 246: | Line 256: | ||
* Pseudopods | * Pseudopods | ||
* Globules | * Globules | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 271: | Line 280: | ||
* '''↑''' atypical spindle shaped melanocytes, | * '''↑''' atypical spindle shaped melanocytes, | ||
* Arranged in single cells or in small nests along the dermoepidermal junction | * Arranged in single cells or in small nests along the dermoepidermal junction | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Development of darker pigmentation, sharper borders, or nodular areas are signs of progression to lentigo maligna melanoma | * Development of darker pigmentation, sharper borders, or nodular areas are signs of progression to lentigo maligna melanoma | ||
Line 292: | Line 300: | ||
* Circle within a circle | * Circle within a circle | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* "Star-burst giant cells" at the basal layer of the epidermis | * "Star-burst giant cells" at the basal layer of the epidermis | ||
* Poorly cohesive or dyshesive nests along the dermal-epidermal junction forming the "swallow's nest" sign | * Poorly cohesive or dyshesive nests along the dermal-epidermal junction forming the "swallow's nest" sign | ||
* Cytoplasm is shrunken and surrounds a pale nucleus with small nucleoli | * Cytoplasm is shrunken and surrounds a pale nucleus with small nucleoli | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Usually in older individuals | * Usually in older individuals | ||
Line 302: | Line 308: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Superficial spreading melanoma''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Superficial spreading melanoma''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Macule | |||
* Plaque with irregular borders | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Variably pigmented (red, blue, black, gray, and white) | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Thin | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* | * 1 mm to > 1 cm | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Anywhere but most commonly: | |||
** Back (men and women) | |||
** Lower extremities (women) | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Asymmetric | |||
* Poorly circumscribed | |||
* Lack cellular maturation | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Lateral (radial) growth before vertical (invasive) growth | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Nodular melanoma''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Nodular melanoma''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Polypoid nodule | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Dark color | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 321: | Line 339: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Cells proliferate downwards through the skin (vertical growth) | |||
* Dermal growth in isolation or in association with an epidermal component | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Two-thirds arise in normal skin, the rest in existing moles | * Two-thirds arise in normal skin, the rest in existing moles | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Acral lentiginous melanoma''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Acral lentiginous melanoma''' | ||
Line 332: | Line 351: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Variable | * Variable | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 343: | Line 361: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Red, nonspecific lesion with slightly elevated borders | | style="background: #F5F5F5; padding: 5px;" |Red, nonspecific lesion with slightly elevated borders | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 367: | Line 384: | ||
* '''↑''' melanin deposition in keratinocytes | * '''↑''' melanin deposition in keratinocytes | ||
* '''↑''' linear arrangement of melanocytes at the dermoepidermal junction. | * '''↑''' linear arrangement of melanocytes at the dermoepidermal junction. | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Associated with UV exposure and skin aging | * Associated with UV exposure and skin aging | ||
Line 377: | Line 393: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Variable | * Variable | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 389: | Line 404: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Variable | * Variable | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 401: | Line 415: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Variable | * Variable | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 412: | Line 425: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Hyperkeratosis | | style="background: #F5F5F5; padding: 5px;" |Hyperkeratosis | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | |
Revision as of 03:03, 19 February 2019
Diseases | Physical exam | Para-clinical findings | Additional findings | ||||||
---|---|---|---|---|---|---|---|---|---|
Skin Examination | |||||||||
Diagnosis | |||||||||
Type | Color | Texture | Size | Distribution | Dermoscopic Findings | Histopathology | |||
Cutaneous squamous cell carcinoma | SCC in situ (Bowen's disease) |
|
|
|
|
|
|
| |
Invasive squamous cell carcinoma |
|
|
|
|
|
|
| ||
Keratoacanthoma |
|
|
|
|
|
|
|
| |
Merkel cell carcinoma |
|
|
|
|
|
|
|
| |
Basal cell carcinoma | Nodular basal cell carcinoma |
|
|
|
|
| |||
Superficial basal cell carcinoma |
|
|
|
|
|
||||
Prurigo nodules |
|
|
|
|
|
|
| ||
Common nevus |
|
|
|
|
|
||||
Blue nevus |
|
|
|
|
|
||||
Spitz nevus | Nonpigmented Spitz nevus |
|
|
|
|
|
| ||
Reed-like Spitz |
|
|
|
|
| ||||
Melanoma | Melanoma in situ (Lentigo Maligna) |
|
|
|
|
|
|
|
|
Lentigo maligna melanoma |
|
|
|
|
|
|
|
| |
Superficial spreading melanoma |
|
|
|
|
|
|
| ||
Nodular melanoma |
|
|
|
|
| ||||
Acral lentiginous melanoma |
|
||||||||
Amelanotic melanoma | Color usually pink, purple or normal skin color | Usually have an asymmetrical shape with an irregular border | Red, nonspecific lesion with slightly elevated borders |
| |||||
Solar lentigo |
|
|
|
|
|
| |||
Sebaceous hyperplasia |
|
||||||||
Lichen planus-like keratosis |
|
||||||||
Seborrheic keratosis |
|
||||||||
Actinic keratosis | less pigmentation, and tend to be somewhat smaller in size. | Erythema | Hyperkeratosis | painful |
SCC in situ: Frequently, there is associated thickening of the epidermis (acanthosis), as well as hyperkeratosis and parakeratosis of the stratum corneum. In contrast to SCC in situ, actinic keratoses demonstrate only partial-thickness epidermal dysplasia.